EP Patent

EP1923058A1 — Coated pharmaceutical composition comprising an S1P agonist or modulator

Assigned to Novartis AG · Expires 2008-05-21 · 18y expired

What this patent protects

The present invention provides an oral pharmaceutical composition comprising an S1P agonist and/or modulator having a coating.

USPTO Abstract

The present invention provides an oral pharmaceutical composition comprising an S1P agonist and/or modulator having a coating.

Drugs covered by this patent

fingolimod-hydrochloride (FINGOLIMOD HYDROCHLORIDE)

Patent Metadata

Patent number: EP1923058A1
Jurisdiction: EP
Classification: —
Expires: 2008-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.